(Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA ...

In a Monday note, Morgan Stanley equity strategist Mike Wilson broke down where investors should rotate their investments to ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $39.3 million in its fiscal second quarter. On a per-share basis, the ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Monday reported a loss of $202.5 million in its first quarter. On a per-share basis, the Salt Lake City-based ...

Move over dragons—there’s a new legendary creature making waves in pop culture, and this time, it’s not a product of fantasy ...

Among the notable speakers this year are Admiral Samuel Paparo, Commander of U.S. Indo-Pacific Command, speaking at Villanova ...

Scholar Rock is shaking up its executive team as it prepares to enter the commercial arena with the expected launch of spinal ...

Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Good day and thank you for standing by. Welcome to the ICON plc Q1 ...

Despite a revenue dip, Icon PLC (ICLR) showcases resilience through strategic partnerships and AI advancements, while ...

Explore ICON plc's Q1 2025 earnings call insights, reflecting challenges in clinical trials, operational innovations, and adjusted guidance.

Icon's balance sheet is sound, with its revenue cyclicality and operating leverage each possessing a medium rating. Icon has historically maintained a fairly conservative balance sheet, and it ended ...

(Reuters) -Amgen on Thursday said its first-quarter profit rose 24%, handily exceeding Wall Street expectations, as product ...